Skip to nav Skip to content
Dr. Roger Li in the operating room
Dr. Roger Li in the operating room

Shaping the Future of Cancer Care

Expert care for prostate, bladder, kidney and other urologic cancers starts at Moffitt Cancer Center.

As part of a nationally recognized cancer center, Moffitt’s urologic oncology team provides patients access to groundbreaking clinical trials, advanced technologies and more treatment options. Our experts have dedicated their lives to studying and treating urologic cancers and have an unparalleled passion for helping patients.

Specialized Care for Every Diagnosis

From common to rare urologic malignancies, we see a high number of patients each year across all diagnoses. That experience means your care is informed by proven expertise and unmatched experience.

Call for an Appointment: 888-663-3488

The Right Treatment. Right Away. Built for You. 

Moffitt offers the most advanced cancer treatment options available, and every treatment plan is collaboratively developed by a team of experts who tailor the treatment to the patient. Some treatment plans include:

  • Surgery with an emphasis on organ‑preservation
  • Chemotherapy
  • Immunotherapy
  • Targeted treatments
  • Radiation therapy 
Advancing Care Through Clinical Trials

Through our clinical trials program, patients may also access promising new therapies, giving patients the chance to benefit from the newest scientific discoveries in cancer care before they are widely available.

Not sure which treatment is right for you? Our team will help you understand your options and what to expect every step of the way.

Schedule an Appointment

Doctor and patient embracing in front of cancer completion bell

The Experts You Have Been Looking For

As a high‑volume, NCI‑designated Comprehensive Cancer Center, our team brings together world-renowned physicians, advanced diagnostics and innovative therapies to guide patients through every step of their cancer journey.

No matter the diagnosis, your care is guided by experts with deep experience treating every type of urologic cancer.

  • Oncology Team
    Jon  Chatzkel, MD

    Program

    Genitourinary Oncology

    Specialty

    Medical Oncology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer

    Mike  Liu, MD

    Program

    Genitourinary Oncology

    Specialty

    Medical Oncology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer

    Jingsong  Zhang, MD, PhD

    Program

    Genitourinary Oncology

    Title

    Interim Vice Chair, Department of Genitourinary Oncology

    Specialty

    Medical Oncology

    Cancer Focus

    Bladder Cancer, Prostate Cancer

    4.8 (257)
    Gigi  Jameel, APRN

    Program

    Genitourinary Oncology

    Specialty

    Medical Oncology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer, Testicular Cancer

    4.8 (172)
    Angel  Johnson, APRN

    Program

    Genitourinary Oncology

    Specialty

    Medical Oncology

    4.9 (145)
    Sarah  Mizelle, PA-C

    Program

    Genitourinary Oncology

    Specialty

    Medical Oncology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer

    4.9 (223)
  • Surgical Team
    Scott  Gilbert, MD

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Testicular Cancer

    4.9 (286)
    Mitchell  Hayes, MD

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Adrenal Cancer, Bladder Cancer, Kidney (Renal Cell) Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer

    Roger  Li, MD

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer

    4.9 (299)
    Joshua  Linscott, MD, PhD

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer

    Adam  Luchey, MD

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer

    4.9 (284)
    Brandon  Manley, MD

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Kidney (Renal Cell) Cancer, Prostate Cancer, Testicular Cancer

    4.9 (190)
    Marilin  Nicholson, MD

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer, Testicular Cancer

    4.8 (291)
    Michael  Poch, MD

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer

    4.8 (270)
    Julio  Pow-Sang, MD
    Department Chair, Genitourinary Oncology
    Program Lead, Genitourinary Oncology

    Program

    Genitourinary Oncology

    Title

    Chair, Department of Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Prostate Cancer

    4.9 (275)
    Rodrigo  Rodrigues Pessoa, MD, PhD

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer, Testicular Cancer

    4.9 (327)
    Wade  Sexton, MD

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Adrenal Cancer, Bladder Cancer, Kidney (Renal Cell) Cancer, Testicular Cancer

    4.9 (219)
    Philippe  Spiess, MD

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Penile Cancer, Testicular Cancer

    4.9 (337)
    Alice  Yu, MD

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Prostate Cancer

    4.9 (188)
    Logan  Zemp, MD

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer, Testicular Cancer

    4.9 (272)
    Eppie  Bass, APRN

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer

    4.9 (350)
    Nicole  Donovan, PA-C

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer

    5 (191)
    Tina  Freamon, APRN

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Penile Cancer, Testicular Cancer

    4.9 (255)
    Lillian  Gonzalez, APRN

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer

    4.9 (298)
    Venkat  Latchana, APRN

    Program

    Genitourinary Oncology

    Specialty

    Urology

    4.8 (151)
    Nikki  Little, APRN

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer

    4.9 (400)
    Rachelle  Rodriguez, APRN

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Adrenal Cancer, Adrenal Nodule/Mass, Bladder Cancer, Kidney (Renal Cell) Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer

    Lane  Rogers, PA-C

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer

    4.9 (126)
    Vonyell  Scrivens

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Priya  Shah

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Weissy  Stylos, PA-C

    Program

    Genitourinary Oncology

    Specialty

    Urology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer

    4.9 (466)
  • Radiation Oncology Team
    Dan  Fernandez, MD, PhD

    Program

    Radiation Oncology

    Specialty

    Radiation Oncology

    Cancer Focus

    Bladder Cancer, Cervical Cancer, Endometrial (Uterine) Cancer, Gastrointestinal Carcinoid Tumor, Kidney (Renal Cell) Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer, Skin Cancer (Nonmelanoma), Testicular Cancer, Vaginal Cancer

    4.9 (154)
    Peter  Johnstone, MD

    Program

    Radiation Oncology

    Specialty

    Radiation Oncology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer, Proton Therapy, Sarcoma, Testicular Cancer

    4.9 (267)
    Javier  Torres-Roca, MD

    Program

    Radiation Oncology

    Specialty

    Radiation Oncology

    Cancer Focus

    Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer, Testicular Cancer

    4.9 (293)
    Kosj  Yamoah, MD, PhD
    Department Chair, Radiation Oncology
    Program Lead, Radiation Oncology

    Program

    Radiation Oncology

    Title

    Chair, Department of Radiation Oncology

    Specialty

    Radiation Oncology

    Cancer Focus

    Prostate Cancer

    4.9 (69)
  • Radiologists
    Ghassan  El-Haddad, MD

    Program

    Diagnostic Imaging and Interventional Radiology

    Title

    Vice Chair, Radiopharmaceutical and Nuclear Oncology

    Specialty

    Interventional Radiology

    4.8 (38)
    Nainesh  Parikh, MD, MBA

    Program

    Diagnostic Imaging and Interventional Radiology

    Specialty

    Interventional Radiology

    4.9 (182)
    Vee  Stewart

    Specialty

    Interventional Radiology

  • Pathology Team
    Jasreman  Dhillon, MD

    Program

    Pathology

    Specialty

    Pathology

    Cancer Focus

    Adrenal Cancer, Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer, Testicular Cancer

If you've received an abnormal test result that could indicate urological cancer, request an appointment with our team today. Moffitt's diagnostic experts will perform the tests needed to diagnose or rule out cancer so you can know for sure.
Request an Appointment

Florida's Top Choice for Cancer Care

The goal of any cancer treatment is to achieve the most favorable outcome while minimizing side effects and ensuring the best possible quality of life. As the only NCI-designated comprehensive cancer center based in Florida, Moffitt’s urologic oncology experts leverage the latest treatments and new research, and our survival rates are higher than the national average. 

Your best chance of beating cancer of the blood is right here in Tampa at Moffitt.

Bladder Cancer - 157% Higher Survival Rates
Kidney Cancer - 54% Higher Survival Rates
Prostate Cancer - 45% Higher Survival Rates
Testicular Cancer - 17% Higher Survival Rates

America's Best Cancer Hospitals Newsweek badge


NCI Comprehensive Cancer Center


Nursing Magnet Recognized

CancerCenter of Excellence logo

Lanse, prostate cancer survivor, hugging his doctor.

Strength Found in Trust and Expertise

Cancer had long been a part of Lanse’s family story, but hearing the diagnosis for himself felt entirely different. Leaning on his faith and Moffitt's expertise, he approached treatment with unwavering resolve. 

Along the journey, he found strength and connection through an unexpected bond with his physician, Dr. Kosj Yamoah.

Dr. Yamoah cares about people and what he’s doing very much. In me, he not only saw a patient but a human being.  

Meet Lanse

Request a New Patient Appointment. No Referral Needed.

Please complete this online form to begin the appointment scheduling process. Most insurance plans do not require a referral for an appointment. A member of our Patient Access team will contact you to schedule an appointment. 

Patient Appointment Center: 888-663-3488
Hours: Monday-Friday, 7am-6pm and Saturday 8am-12pm ET.

What You'll Need

Whether you call us or complete the online form below, you'll need to have a few things ready:

  • Patient's full name, contact information and date of birth
  • Reason for visit
  • Patient's primary insurance information

Appointment Details

What best describes your first appointment at Moffitt?
Would you be interested in learning about clinical trials at Moffitt?
Do you have an insulin pump or glucose monitor?
Have you ever had a Mammogram before?
Have you ever been diagnosed with breast cancer?
Are you currently experiencing any breast problems?
Are you 50 years of age or older?
Have you ever had a Lung Screening CT before?
Do you have a primary care provider?
Are you interested in smoking cessation resources?
How were you referred to Moffitt?

Appointment Preferences

Do you have a preferred Moffitt location?
Are you requesting to see a specific Moffitt provider?

Patient Contact Information

By checking this box, I consent to receive automated SMS messages from Moffitt Cancer Center regarding my inquiry.

Patient Insurance Information

Is the patient the policy holder?
Does the patient have secondary insurance, or a Medicare Supplement (Medigap) Plan?